{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:33:31Z","timestamp":1791077611748,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.mcna.2010.02.008","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T08:31:07Z","timestamp":1273134667000},"page":"541-555","source":"Crossref","is-referenced-by-count":15,"title":["Advances in Narcolepsy"],"prefix":"10.1016","volume":"94","author":[{"given":"Michelle","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2010.02.008_bib1","doi-asserted-by":"crossref","first-page":"3475","DOI":"10.1073\/pnas.88.8.3475","article-title":"Genetic linkage of autosomal recessive canine narcolepsy with a mu immunoglobulin heavy-chain switch-like segment","volume":"88","author":"Mignot","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mcna.2010.02.008_bib2","series-title":"International classification of sleep disorders: diagnostic and coding manual. 2nd edition","author":"American Academy of Sleep Medicine","year":"2005"},{"key":"10.1016\/j.mcna.2010.02.008_bib3","series-title":"Narcolepsy and hypersomnia","author":"Roth","year":"1980"},{"key":"10.1016\/j.mcna.2010.02.008_bib4","series-title":"HLA in narcolepsy","first-page":"24","article-title":"Clinical features of narcolepsy","author":"Honda","year":"1988"},{"key":"10.1016\/j.mcna.2010.02.008_bib5","series-title":"Sleep medicine","first-page":"193","article-title":"Narcolepsy and idiopathic hypersomnia","author":"Brooks","year":"2002"},{"issue":"3","key":"10.1016\/j.mcna.2010.02.008_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0733-8619(05)70273-5","article-title":"Narcolepsy","volume":"14","author":"Bassetti","year":"1996","journal-title":"Neurol Clin"},{"key":"10.1016\/j.mcna.2010.02.008_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1748-1716.2009.02012.x","article-title":"Hypocretin\/orexin and narcolepsy: new basic and clinical insights","volume":"198","author":"Nishino","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.mcna.2010.02.008_bib8","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1399-0039.1984.tb02144.x","article-title":"HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive","volume":"24","author":"Juji","year":"1984","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.mcna.2010.02.008_bib9","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0301-0082(96)00070-6","article-title":"Pharmacological aspects of human and canine narcolepsy","volume":"52","author":"Nishino","year":"1997","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mcna.2010.02.008_bib10","first-page":"1012","article-title":"HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients","volume":"20","author":"Mignot","year":"1997","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib11","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamic-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mcna.2010.02.008_bib12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.mcna.2010.02.008_bib13","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0092-8674(00)81965-0","article-title":"The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene","volume":"98","author":"Lin","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mcna.2010.02.008_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0092-8674(00)81973-X","article-title":"Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation","volume":"98","author":"Chemelli","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.mcna.2010.02.008_bib16","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(01)00293-8","article-title":"Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity","volume":"30","author":"Hara","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.mcna.2010.02.008_bib17","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/79690","article-title":"A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains","volume":"6","author":"Peyron","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.mcna.2010.02.008_bib18","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(07)60237-2","article-title":"Narcolepsy with cataplexy","volume":"369","author":"Dauvilliers","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2010.02.008_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0896-6273(00)00058-1","article-title":"Reduced number of hypocretin neurons in human narcolepsy","volume":"27","author":"Thannickal","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.mcna.2010.02.008_bib20","doi-asserted-by":"crossref","first-page":"e4254","DOI":"10.1371\/journal.pone.0004254","article-title":"IGFBP3 colocalizes with and regulates hypocretin (orexin)","volume":"4","author":"Honda","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2010.02.008_bib21","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1212\/01.wnl.0000175219.01544.c8","article-title":"Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy","volume":"65","author":"Blouin","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2010.02.008_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/01.WNL.0000168173.71940.ab","article-title":"Concomitant loss of dynorphin, NARP, and orexin in narcolepsy","volume":"65","author":"Crocker","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2010.02.008_bib23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1093\/sleep\/25.7.719","article-title":"Search for neuron-specific and non-neuron specific antibodies in narcoleptic patients with an without HLA DQB1*0602","volume":"25","author":"Black","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib24","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biopsych.2005.04.026","article-title":"Studies of humoral immunity to pre-prohypocretin in human leukocyte antigen DQB1*0602 positive narcoleptic subjects with cataplexy","volume":"58","author":"Black","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.mcna.2010.02.008_bib25","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1212\/WNL.50.2_Suppl_1.S16","article-title":"Genetic and familial aspects of narcolepsy","volume":"50","author":"Mignot","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2010.02.008_bib26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1034\/j.1399-0039.1999.540204.x","article-title":"Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy","volume":"54","author":"Hohjoh","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.mcna.2010.02.008_bib27","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1016\/j.humimm.2004.07.209","article-title":"Association of TNF-alpha gene promoter polymorphism with narcolepsy-cataplexy in Koreans","volume":"65","author":"Park","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.mcna.2010.02.008_bib28","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1086\/505539","article-title":"Genome wide association analysis of human narcolepsy and a new resistance gene","volume":"79","author":"Kawashima","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.mcna.2010.02.008_bib29","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ng.231","article-title":"Variant between CPT1B and CHKB associated with susceptibility to narcolepsy","volume":"40","author":"Miyagawa","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/j.mcna.2010.02.008_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1034\/j.1399-0039.2000.560508.x","article-title":"Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy","volume":"56","author":"Hohjoh","year":"2000","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.mcna.2010.02.008_bib31","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.372","article-title":"Narcolepsy is strongly associated with the T-cell receptor alpha locus","volume":"41","author":"Hallmayer","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.mcna.2010.02.008_bib32","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1748-1716.2009.02004.x","article-title":"A decade of hypocretins: past, present, and future of the neurobiology of arousal","volume":"198","author":"De Lecea","year":"2010","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1016\/j.mcna.2010.02.008_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/187152709788921645","article-title":"The hypocretins and their role in narcolepsy","volume":"8","author":"Kroeger","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.mcna.2010.02.008_bib34","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1523\/JNEUROSCI.19-03-01072.1999","article-title":"Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations","volume":"19","author":"Horvath","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(03)03257-8","article-title":"Immunoelectron microscopic examination of orexin-like immunoreactive fibers in the dorsal horn of the rat spinal cord","volume":"987","author":"Guan","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.mcna.2010.02.008_bib36","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1523\/JNEUROSCI.19-08-03171.1999","article-title":"Hypothalamic hypocretin (orexin): robust innervation of the spinal cord","volume":"19","author":"Van den Pol","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/S0196-9781(99)00157-6","article-title":"Differential distribution of orexin-A and orexin-B immunoreactivity in the rat brain and spinal cord","volume":"20","author":"Cutler","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.mcna.2010.02.008_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.neuropharm.2008.06.060","article-title":"Role of lateral hypothalamic orexin neurons in reward processing and addiction","volume":"56","author":"Aston-Jones","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.mcna.2010.02.008_bib39","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nature04071","article-title":"A role for lateral hypothalamic orexin neurons in reward seeking","volume":"437","author":"Harris","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.mcna.2010.02.008_bib40","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.0953-816x.2001.01518.x","article-title":"SB-334867, a selective orexin-1 receptor antagonist, enhances behavioral satiety and blocks the hyperphagic effect of orexin-A in rats","volume":"13","author":"Rodgers","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0143-4179(02)00085-9","article-title":"Orexins and appetite regulation","volume":"36","author":"Rodgers","year":"2002","journal-title":"Neuropeptides"},{"key":"10.1016\/j.mcna.2010.02.008_bib42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0167-0115(00)00199-3","article-title":"A selective orexin-1 receptor antagonist reduces food consumption in male and female rats","volume":"96","author":"Haynes","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.mcna.2010.02.008_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0361-9230(01)00756-0","article-title":"Chronic central infusion of orexin-A increases arterial pressure in rats","volume":"57","author":"Lin","year":"2002","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.mcna.2010.02.008_bib44","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0196-9781(99)00105-9","article-title":"Effects of single and chronic intracerebroventricular administration of orexins on feeding in the rat","volume":"20","author":"Haynes","year":"1999","journal-title":"Peptides"},{"key":"10.1016\/j.mcna.2010.02.008_bib45","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0006-8993(99)01905-8","article-title":"Chronic intracerebroventricular administration of orexin-A to rats increases food intake in daytime, but has no effect on body weight","volume":"849","author":"Yamanaka","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.mcna.2010.02.008_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(99)01336-0","article-title":"Distribution of orexin neurons in the adult rat brain","volume":"827","author":"Nambu","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.mcna.2010.02.008_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrn2092","article-title":"The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness","volume":"8","author":"Sakurai","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cmet.2008.10.010","article-title":"Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity","volume":"9","author":"Funato","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.mcna.2010.02.008_bib49","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1523\/JNEUROSCI.2761-05.2006","article-title":"Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine","volume":"26","author":"Narita","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib50","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1523\/JNEUROSCI.23-08-03106.2003","article-title":"Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal","volume":"23","author":"Georgescu","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0031-9384(92)90442-5","article-title":"Metabolic and neuroendocrine indices one month after lateral hypothalamic area lesions","volume":"52","author":"Bernardis","year":"1992","journal-title":"Physiol Behav"},{"key":"10.1016\/j.mcna.2010.02.008_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1469-7793.2001.0161k.x","article-title":"Electrophysiological and morphological properties of pre-autonomic neurons in the rat hypothalamic paraventricular nucleus","volume":"537","author":"Stern","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/j.mcna.2010.02.008_bib53","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1097\/00001756-200006260-00034","article-title":"Centrally administered orexin\/hypocretin activates HPA axis in rats","volume":"11","author":"Kuru","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.mcna.2010.02.008_bib54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.regpep.2003.12.014","article-title":"Centrally administered orexin-A activates corticotropin-releasing factor-containing neurons in the hypothalamic paraventricular nucleus and central orexins on stress-activated central CRF neurons","volume":"118","author":"Sakamoto","year":"2004","journal-title":"Regul Pept"},{"key":"10.1016\/j.mcna.2010.02.008_bib55","doi-asserted-by":"crossref","first-page":"R1780","DOI":"10.1152\/ajpregu.1999.277.6.R1780","article-title":"Sympathetic and cardiovascular actions of orexins in conscious rats","volume":"277","author":"Shirasaka","year":"1999","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"3","key":"10.1016\/j.mcna.2010.02.008_bib56","doi-asserted-by":"crossref","first-page":"R533","DOI":"10.1152\/ajpregu.00887.2005","article-title":"Elevated body temperature during sleep in orexin knock out mice","volume":"1","author":"Mochizuki","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mcna.2010.02.008_bib57","doi-asserted-by":"crossref","unstructured":"Han F, Mignot E, Wei YC, et\u00a0al. Ventilatory chemoresponsiveness, narcolepsy-cataplexy, and HLA DQB1*0602 staus. Eur Respir J 2010, in press.","DOI":"10.1183\/09031936.00174609"},{"key":"10.1016\/j.mcna.2010.02.008_bib58","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1212\/WNL.43.1_Part_1.55","article-title":"The positive diagnosis of narcolepsy and narcolepsy's borderland","volume":"43","author":"Moscovitch","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2010.02.008_bib59","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/0301-0082(93)90042-Q","article-title":"The neurobiology of narcolepsy-cataplexy","volume":"41","author":"Aldrich","year":"1993","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.mcna.2010.02.008_bib60","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/01.WNL.0000101725.34089.1E","article-title":"Effect of age on MSLT results in patients with narcolepsy-cataplexy","volume":"62","author":"Dauvilliers","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.mcna.2010.02.008_bib61","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/sleep\/29.7.890","article-title":"The prevalence of multiple sleep-onset REM periods in a population-based sample","volume":"29","author":"Singh","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib62","series-title":"HLA in narcolepsy","first-page":"10","year":"1988"},{"issue":"5","key":"10.1016\/j.mcna.2010.02.008_bib63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(99)05582-8","article-title":"Hypocretin (orexin) deficiency in human narcolepsy","volume":"35","author":"Nishino","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2010.02.008_bib64","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1001\/archneur.59.10.1553","article-title":"The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias","volume":"59","author":"Mignot","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mcna.2010.02.008_bib65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.smrv.2005.03.004","article-title":"Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin\/orexin system","volume":"9","author":"Nishino","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.mcna.2010.02.008_bib66","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archneurol.2009.264","article-title":"Symptomatic narcolepsy in patients with neuromyelitis optica and multiple sclerosis: new neurochemical and immunological implications","volume":"66","author":"Kanbayashi","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mcna.2010.02.008_bib67","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1093\/sleep\/16.3.216","article-title":"Gammahydroxybutyrate and narcolepsy: a double-blind placebo-controlled study","volume":"16","author":"Lammers","year":"1993","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib68","first-page":"42","article-title":"A randomized, double blind, multicenter trial comparing the effect of 3 doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy","volume":"25","author":"U.S. Xyrem Multicenter Study Group","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib69","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1177\/0091270003262795","article-title":"The pharmacokinetics of sodium oxybate oral solution following acute and chronic administration to narcoleptic patients","volume":"44","author":"Borgen","year":"2004","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.mcna.2010.02.008_bib70","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pediatrneurol.2009.02.008","article-title":"Narcolepsy: action of two \u03b3-aminobutyric acid type B agonists, baclofen and sodium oxybate","volume":"41","author":"Huang","year":"2009","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.mcna.2010.02.008_bib71","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/01.wnl.0000239827.38036.23","article-title":"Effect of intrathecal baclofen on sleep and respiratory function in patients with spasticity","volume":"67","author":"Bensmail","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2010.02.008_bib72","first-page":"222","article-title":"The effects and effectiveness of gamma-hydroxybutyrate in patients with narcolepsy","volume":"46","author":"Scharf","year":"1985","journal-title":"J Clin Psychol"},{"issue":"8","key":"10.1016\/j.mcna.2010.02.008_bib73","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.sleep.2009.05.004","article-title":"The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy","volume":"10","author":"Black","year":"2009","journal-title":"Sleep Med"},{"issue":"5","key":"10.1016\/j.mcna.2010.02.008_bib74","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1523\/JNEUROSCI.21-05-01787.2001","article-title":"Dopaminergic role in stimulant-induced wakefulness","volume":"21","author":"Wisor","year":"2001","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.mcna.2010.02.008_bib75","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/sleep\/17.5.436","article-title":"Modafinil binds to the dopamine uptake carrier site with low affinity","volume":"15","author":"Mignot","year":"1994","journal-title":"Sleep"},{"issue":"7","key":"10.1016\/j.mcna.2010.02.008_bib76","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1093\/sleep\/29.7.939","article-title":"Sodium oxybate improves excessive daytime sleepiness in narcolepsy","volume":"29","author":"Black","year":"2006","journal-title":"Sleep"},{"issue":"3","key":"10.1016\/j.mcna.2010.02.008_bib77","first-page":"557","article-title":"Narcolepsy: current treatment options and future approaches","volume":"4","author":"Billiard","year":"2008","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.mcna.2010.02.008_bib78","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/13543784.17.4.565","article-title":"Armodafinil: a new treatment for excessive sleepiness","volume":"17","author":"Lankford","year":"2008","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.mcna.2010.02.008_bib79","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1185\/030079906X100050","article-title":"The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy","volume":"22","author":"Harsh","year":"2006","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"10.1016\/j.mcna.2010.02.008_bib80","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2165\/11203290-000000000-00000","article-title":"Armodafinil","volume":"23","author":"Garmock-Jones","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.mcna.2010.02.008_bib81","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.sleep.2007.03.004","article-title":"Therapeutic advances in narcolepsy","volume":"8","author":"Thorpy","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.mcna.2010.02.008_bib82","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1073\/pnas.0400590101","article-title":"Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice","volume":"101","author":"Mieda","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.mcna.2010.02.008_bib83","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.sleep.2007.03.008","article-title":"Clinical and neurobiological aspects of narcolepsy","volume":"8","author":"Nishino","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.mcna.2010.02.008_bib84","first-page":"66","article-title":"Intranasal administration of hypocretin 1 (orexin A) bypasses the blood-brain barrier & targets the brain: a new strategy for the treatment of narcolepsy","volume":"4","author":"Hanson","year":"2004","journal-title":"Drug Delivery Technol"},{"key":"10.1016\/j.mcna.2010.02.008_bib85","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler","year":"2007","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.mcna.2010.02.008_bib86","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1046\/j.1365-2869.2003.00380.x","article-title":"Clinical efficacy of high-dose intravenous immunoglobins near the onset of narcolepsy in a 10-year old boy","volume":"12","author":"Lecendreux","year":"2003","journal-title":"J Sleep Res"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2010.02.008_bib87","first-page":"828","article-title":"Variable response to intravenous immunoglobulin therapy in childhood narcolepsy","volume":"13","author":"Zuberi","year":"2004","journal-title":"J Sleep Res"},{"issue":"6","key":"10.1016\/j.mcna.2010.02.008_bib88","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.20339","article-title":"Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset","volume":"56","author":"Dauvilliers","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.mcna.2010.02.008_bib89","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.drudis.2009.02.011","article-title":"The histamine H3 receptor as a therapeutic drug target for CNS disorders","volume":"14","author":"Gemkow","year":"2009","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.mcna.2010.02.008_bib90","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1523\/JNEUROSCI.17-16-06401.1997","article-title":"Effects of thyrotropin-releasing hormone and its analogs on daytime sleepiness and cataplexy in canine narcolepsy","volume":"17","author":"Nishino","year":"1997","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.mcna.2010.02.008_bib91","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.107.135343","article-title":"Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists","volume":"325","author":"Le","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.mcna.2010.02.008_bib92","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.bcp.2007.01.002","article-title":"The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders","volume":"73","author":"Parmentier","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.mcna.2010.02.008_bib93","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/sj.bjp.0705964","article-title":"Acute wake-promoting actions of JNJ-5207852, a novel, diamine-based H3 antagonist","volume":"143","author":"Barbier","year":"2004","journal-title":"Br J Pharmacol"},{"issue":"Abstract Suppl","key":"10.1016\/j.mcna.2010.02.008_bib94","first-page":"S241","article-title":"Wake promoting effects of thioperamide, a histamine H3 antagonist in orexin\/ataxin-3 narcoleptic mice","volume":"27","author":"Shiba","year":"2004","journal-title":"Sleep"},{"issue":"2","key":"10.1016\/j.mcna.2010.02.008_bib95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/nrd1631","article-title":"The histamine H-3 receptor: from gene cloning to H-3 receptor drugs","volume":"4","author":"Leurs","year":"2005","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.mcna.2010.02.008_bib96","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H-3 receptor improves wakefulness in narcolepsy: studies in orexin(-\/-) mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mcna.2010.02.008_bib97","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/sleep\/29.11.1444","article-title":"Altered skin-temperature regulation in narcolepsy relates to sleep propensity","volume":"11","author":"Fronczek","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.mcna.2010.02.008_bib98","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/43366","article-title":"Warm feet promote the rapid onset of sleep","volume":"6748","author":"Krauchi","year":"1999","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mcna.2010.02.008_bib99","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/sleep\/31.2.233","article-title":"Manipulation of core body and skin temperature improves vigilance and maintenance of wakefulness in narcolepsy","volume":"31","author":"Fronczek","year":"2008","journal-title":"Sleep"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712510000222?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712510000222?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T00:26:59Z","timestamp":1559089619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712510000222"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":99,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0025712510000222"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2010.02.008","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}